Similar clinical benefits from below-target and target dose enalapril in patients with heart failure in the SOLVD Treatment trial
2017 | journal article. A publication with affiliation to the University of Göttingen.
Jump to: Cite & Linked | Documents & Media | Details | Version history
Cite this publication
Similar clinical benefits from below-target and target dose enalapril in patients with heart failure in the SOLVD Treatment trial
Lam, P. H.; Dooley, D. J.; Fonarow, G. C.; Butler, J.; Bhatt, D. L.; Filippatos, G. S. & Deedwania, P. et al. (2017)
European Journal of Heart Failure, 20(2) pp. 359-369. DOI: https://doi.org/10.1002/ejhf.937
Documents & Media
Details
- Title Variant(s)
- Below-target vs. target doses of enalapril and outcomes in heart failure
- Authors
- Lam, Phillip H.; Dooley, Daniel J.; Fonarow, Gregg C.; Butler, Javed; Bhatt, Deepak L.; Filippatos, Gerasimos S.; Deedwania, Prakash; Forman, Daniel E.; White, Michel; Fletcher, Ross D.; Arundel, Cherinne; Blackman, Marc R.; Adamopoulos, Chris; Kanonidis, Ioannis E.; Aban, Inmaculada B.; Patel, Kanan; Aronow, Wilbert S.; Allman, Richard M.; Anker, Stefan D. ; Pitt, Bertram; Ahmed, Ali
- Issue Date
- 2017
- Journal
- European Journal of Heart Failure
- ISSN
- 1388-9842
- Language
- English
